久久一区二区三区四区_欧美高清dvd_日韩欧美在线看_国产精品欧美一区二区_av天天看_欧美精品免费观看二区

加拿大YM BioSciences
是為全球病人一家從事癌癥藥物及急救藥品研發及商業化的公司。

YM BioSciences is a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization.

The Company is currently advancing two late-stage products:

Nimotuzumab: an EGFR-targeting Affinity-Optimized Antibody? in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation, and approved for marketing in over 12 countries.

AeroLEF?: a proprietary, inhaled-delivery composition of fentanyl in development for the treatment of moderate to severe acute pain.